397 related articles for article (PubMed ID: 32707288)
1. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
Nambou K; Anakpa M
Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of protein synthesis rate in COVID-19 with other human coronaviruses.
Dasari CM; Bhukya R
Infect Genet Evol; 2020 Nov; 85():104432. PubMed ID: 32592845
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
Das JK; Roy S
Genomics; 2021 Jul; 113(4):2177-2188. PubMed ID: 34019999
[TBL] [Abstract][Full Text] [Related]
4. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
5. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.
Huang W; Guo Y; Li N; Feng Y; Xiao L
Infect Genet Evol; 2021 Apr; 89():104736. PubMed ID: 33516969
[TBL] [Abstract][Full Text] [Related]
6. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects.
Maldonado LL; Bertelli AM; Kamenetzky L
Sci Rep; 2021 Feb; 11(1):4108. PubMed ID: 33602998
[TBL] [Abstract][Full Text] [Related]
7. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2.
Li G; Zhang L; Xue P
Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776
[TBL] [Abstract][Full Text] [Related]
8. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.
Li Y; Yang X; Wang N; Wang H; Yin B; Yang X; Jiang W
Mol Genet Genomics; 2020 Nov; 295(6):1537-1546. PubMed ID: 32888056
[TBL] [Abstract][Full Text] [Related]
9. Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.
Dilucca M; Forcelloni S; Georgakilas AG; Giansanti A; Pavlopoulou A
Viruses; 2020 Apr; 12(5):. PubMed ID: 32366025
[TBL] [Abstract][Full Text] [Related]
10. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.
Li G; Zhang L; Du N
Genes Genomics; 2021 Nov; 43(11):1351-1359. PubMed ID: 34228320
[TBL] [Abstract][Full Text] [Related]
11. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.
Saha J; Bhattacharjee S; Pal Sarkar M; Saha BK; Basak HK; Adhikary S; Roy V; Mandal P; Chatterjee A; Pal A
Gene Rep; 2021 Jun; 23():101055. PubMed ID: 33615042
[TBL] [Abstract][Full Text] [Related]
12. Characterization of codon usage pattern in SARS-CoV-2.
Hou W
Virol J; 2020 Sep; 17(1):138. PubMed ID: 32928234
[TBL] [Abstract][Full Text] [Related]
13. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.
Lopes EN; Fonseca V; Frias D; Tosta S; Salgado Á; Assunção Vialle R; Paulo Eduardo TS; Barreto FK; Ariston de Azevedo V; Guarino M; Angeletti S; Ciccozzi M; Junior Alcantara LC; Giovanetti M
J Med Virol; 2021 Sep; 93(9):5630-5634. PubMed ID: 33934387
[TBL] [Abstract][Full Text] [Related]
14. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).
Tyagi N; Sardar R; Gupta D
PeerJ; 2022; 10():e13562. PubMed ID: 35765592
[TBL] [Abstract][Full Text] [Related]
15. Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts.
Carmi G; Gorohovski A; Mukherjee S; Frenkel-Morgenstern M
FEBS J; 2021 Sep; 288(17):5201-5223. PubMed ID: 33756061
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
Khattak S; Rauf MA; Zaman Q; Ali Y; Fatima S; Muhammad P; Li T; Khan HA; Khan AA; Ngowi EE; Wu DD; Ji XY
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207362
[TBL] [Abstract][Full Text] [Related]
17. The characteristic of the synonymous codon usage and phylogenetic analysis of hepatitis B virus.
Qi X; Wei C; Li Y; Wu Y; Xu H; Guo R; Jia Y; Li Z; Wei Z; Wang W; Jia J; Li Y; Wang A; Gao X
Genes Genomics; 2020 Jul; 42(7):805-815. PubMed ID: 32462516
[TBL] [Abstract][Full Text] [Related]
18. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
19. Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.
Mogro EG; Bottero D; Lozano MJ
Virology; 2022 Mar; 568():56-71. PubMed ID: 35134624
[TBL] [Abstract][Full Text] [Related]
20. Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses.
Chen Z; Boon SS; Wang MH; Chan RWY; Chan PKS
J Virol Methods; 2021 Mar; 289():114032. PubMed ID: 33290786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
